Purchase Order 75N92024P00243
Award Date
7/25/24
Potential Completion Date
9/30/24
Potential Value
$19K
Federal Agency
National Heart Lung and Blood Institute
Awardee
Zen-Bio, Inc.
Ultimate Awardee
Not listed
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Durham, NC 27713, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
3
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm-fixed-price contract awarded by the Centers for Disease Control and Prevention (CDC) to Zen-Bio, Inc., a for-profit manufacturer of human blood products located in Durham, North Carolina. The contract, valued at $87,624.00, is a Blanket Purchase Agreement (BPA) call order that allows the CDC to efficiently procure specialized blood units and related biological materials from Zen-Bio to support the agency's disease monitoring, prevention, and research efforts. The contract has a...
This is a firm fixed-price definitive contract awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency, to Zen-Bio, Inc. (doing business as Zenbio), a for-profit manufacturer of human blood products and related biological services. The $224,901 contract is for high content screening to identify human primary pancreatic cell type-specific toxicants. This is a small business set-aside contract with a completion date of March 14, 2016. Zenbio has been...
This contract, awarded by the Defense Health Agency (DHA) to Zen-Bio, Inc. (Zenbio), provides screened human blood products to support malaria vaccine research conducted by the Walter Reed Army Institute of Research (WRAIR). The $206,163 firm fixed-price award covers the delivery of O+ packed red blood cells every two weeks and A+ human male serum on a monthly basis. This contract is not set-aside and was competitively awarded. Zenbio, a for-profit manufacturer of human blood products, has...
The National Heart, Lung, and Blood Institute (NHLBI), a civilian agency within the U.S. Department of Health and Human Services, awarded a firm fixed-price contract valued at $18,120.00 to Stemcell Technologies Inc., a foreign-owned, for-profit biotechnology company based in Canada. The contract is a Blanket Purchase Agreement (BPA) call, with an ultimate completion date of May 18, 2025. The purpose of the contract is to provide cell purification kits to the NHLBI LEONARD LAB in order to purify...
This federal contract award, valued at $76,361.60, was issued by the National Heart Lung and Blood Institute (NHLBI), a civilian agency within the U.S. Department of Health and Human Services. The award is a Delivery Order placed under the Multiple Award Schedule (MAS) contract vehicle. The contract was awarded to Government Scientific Source Inc., a for-profit small business organization, to provide a single-cell multiome reagent bundle, single-cell 3' kit V3.1, Chip G kit, Chip J kit, single...
This federal contract award, valued at $75,650.00, was issued by the National Heart Lung and Blood Institute (NHLBI), a civilian agency within the U.S. Department of Health and Human Services, to STEMCELL Technologies Inc., a foreign-owned, for-profit biotechnology company headquartered in Canada. The contract is a firm fixed-price purchase order with no small business set-aside designation. The award supports the NHLBI's biomedical research activities by providing specialized biological...
The Department of Health and Human Services Health Resources and Services Administration (HRSA) awarded a $13,800,876 definitive, firm-fixed-price contract to The Abraham J & Phyllis Katz Cord Blood Foundation, doing business as the Cleveland Cord Blood Center, a non-profit organization and manufacturer of goods. The contract supports the National Cord Blood Inventory (NCBI) program, which aims to build a repository of at least 150,000 new, genetically diverse cord blood units for...
The National Heart, Lung, and Blood Institute (NHLBI), a civilian agency within the U.S. Department of Health and Human Services, has awarded a $12,925.85 firm-fixed-price purchase order to Biowest USA Inc., a for-profit organization, for the procurement of fetal bovine serum. The serum will be used to support a T-cell activation process study in normal and pathological states. This purchase order, which does not have a set-aside designation, has a performance period ending on December 9,...
This firm fixed-price purchase order was awarded by the National Institutes of Health (NIH) Clinical Center, a civilian federal agency, to the American Association of Blood Banks (AABB), a non-profit organization. The $201,021.36 contract tasks AABB with supplying red blood cells, platelets, and fresh frozen plasma to support the NIH Clinical Center's research programs and patient care activities. This award is associated with a larger $1.8 million single-award Indefinite Delivery Contract (IDC)...
The Department of Health and Human Services awarded a $12,313,923 firm fixed price contract to the New York Blood Center (NYBC), a nonprofit organization, to collect and maintain genetically diverse, high-quality umbilical cord blood units for the National Cord Blood Inventory. This is part of the 5th cohort of the Cord Blood Inventory program. The contract has an ultimate completion date of September 24, 2028 and was awarded on September 10, 2010. There was no set-aside designation for this...